Clinical Study
Eye (2007) 21, 331–332. doi:10.1038/sj.eye.6702172; published online 11 November 2005
Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin
1Department of Ophthalmology, King Edward VII Hospital, Windsor, Berkshire, UK
Correspondence: A Gurbaxani, Department of Ophthalmology, King Edward VII Hospital, St Leonard Road, Windsor, Berkshire SL4 3DP, UK. Tel: +44 797 729 6469; Fax: +44 175 368 0441; E-mail: avigurbaxani@ yahoo.co.in
Received 15 September 2005; Revised 20 September 2005; Accepted 23 September 2005; Published online 11 November 2005.
Abstract
Purpose
To describe the use of intracameral phenylephrine to prevent the floppy iris syndrome seen in patients who are on the drug tamsulosin for benign prostatic hypertrophy, during cataract surgery.
Setting
Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berkshire, UK.
Method
Seven patients who were on systemic tamsulosin for benign prostatic hypertrophy received intracameral phenylephrine before capsulorexhis during their cataract surgery.
Results
There was a significant reduction in the amount of mobility of the iris, reduction in the expected fluttering, and sustained papillary dilatation.
Conclusion
Intracameral phenylephrine is a simple and effective tool to prevent the effects of floppy iris syndrome in those patients undergoing cataract surgery who are on systemic tamsulosin.
Keywords:
intracameral, phenylephrine, tamsulosin, floppy iris, cataract surgery, small pupil
